detlev: it is a type of engineering.t is this genome scissor which eliminates, which can cut precisely at a specific place and it cuts at the place where the virus is integrated in the genome of the patient. and then it can be cut out. brent: the place where the virus connects, especially to the t cells, that place will be blocked by this method. is there any risk to a human being if this process is carried out? detlev: well, these experiments have been successful in three mice out of seven. so it's a 30%, 40% success rate in mice. this has never been tried in men and it will take some time before it can be introduced in men in clinical trials. so, there is hope and we know where to go. and this is obviously a very promising way of new therapies, but the therapy is not yet there and it may be years before it is really effective. brent: that is what i wanted to ask you, what does the calendar look like from where we are right now to clinical trials to maybe even having this as a treatment or a cure? detlev: it is very har